14.25
Alpha Tau Medical Ltd stock is traded at $14.25, with a volume of 312.01K.
It is down -1.72% in the last 24 hours and up +15.48% over the past month.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
See More
Previous Close:
$14.50
Open:
$14.41
24h Volume:
312.01K
Relative Volume:
0.38
Market Cap:
$1.29B
Revenue:
-
Net Income/Loss:
$-56.88M
P/E Ratio:
-21.58
EPS:
-0.6604
Net Cash Flow:
$-39.43M
1W Performance:
+8.45%
1M Performance:
+15.48%
6M Performance:
+97.64%
1Y Performance:
+345.31%
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Compare DRTS vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd
|
14.25 | 1.25B | 0 | -56.88M | -39.43M | -0.6604 |
|
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
|
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-15-23 | Initiated | Citigroup | Buy |
| Apr-24-23 | Initiated | H.C. Wainwright | Buy |
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-08-22 | Initiated | Piper Sandler | Overweight |
| Apr-04-22 | Initiated | Citigroup | Buy |
View All
Alpha Tau Medical Ltd Stock (DRTS) Latest News
Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy? - simplywall.st
Alpha Tau Medical (XTAE:DRTS) Cyclically Adjusted Price-to-FCF : (As of Aug. 14, 2026) - GuruFocus
Alpha Tau Medical (XTAE:DRTS) Shiller PE Ratio : (As of Aug. 14, 2026) - GuruFocus
Q3 EPS Estimate for Alpha Tau Medical Decreased by Analyst - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Stock Price Down 5.4% Following Insider Selling - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) CFO Sells $248,220.00 in Stock - MarketBeat
H.C. Wainwright raises Alpha Tau Medical stock price target to $16 - Investing.com
Five Takeaways from AHNS 2026: Alpha DaRT in Combination with Immunotherapy for Advanced Head and Neck Cancer - Alpha Tau Medical
ALPHA TAU MEDICAL LTD. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $16 FROM $15 - webull.com
Alpha Tau Medical (DRTS) Clinical Progress Tests Whether The Stock Already Looks Fully Valued - simplywall.st
Alpha Tau Medical stock hits 52-week high at 14.12 USD - Investing.com India
Alpha Tau Medical Ltd Cash Flow – TASE:DRTS - TradingView
Free cash flow per share of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Alpha Tau Medical (NASDAQ:DRTS) Hits New 12-Month High Following Analyst Upgrade - MarketBeat
Price to sales ratio of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Alpha Tau Medical Ltd Balance Sheet – TASE:DRTS - TradingView
Preferred dividends of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
HC Wainwright Issues Positive Forecast for Alpha Tau Medical (NASDAQ:DRTS) Stock Price - MarketBeat
Alpha Tau Medical Ltd. (DRTS) stock price, news, quote and history - Yahoo Finance UK
Alpha Tau Medical Ltd. (DRTS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alpha Tau Medical Reports H1 2026 Results Amid Major Clinical and Commercial Milestones - scanx.trade
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update - Alpha Tau Medical
Alpha Tau Medical (NASDAQ:DRTS) Releases Earnings Results, Misses Estimates By $0.36 EPS - MarketBeat
Alpha Tau Medical (DRTS) widens loss as Tolmar deal boosts cash and milestones - Stock Titan
Alpha Tau Medical Files for Dual Listing on Tel Aviv Stock Exchange - marketscreener.com
Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) - Caledonian Record
Alpha Tau Medical (NASDAQ: DRTS) moves to dual-list shares on TASE - Stock Titan
Alpha Tau Medical (DRTS) Earnings Date and Reports 2026 $DRTS - MarketBeat
DRTS Stock Price, Quote & Chart - ChartMill
DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week - stocktwits.com
Alpha Tau Medical (NASDAQ:DRTS) Stock Rating Upgraded by Zacks Research - MarketBeat
Alpha Tau Medical (DRTS) Expected to Post Earnings on Monday - MarketBeat
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial - Yahoo Finance
Alpha Tau Medical Ltd. Revenue Breakdown – NASDAQ:DRTSW - tradingview.com
DRTS|Alpha Tau Medical Ltd|Price:12.200|Chg%:-0.300 - TradingKey
Alpha Tau Medical Ltd (DRTS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alpha Tau Medical (DRTS) Clinical Win Puts Its Pricey Valuation Back In Focus - simplywall.st
Alpha Tau Medical Ltd (DRTS) Cash Flow - TradingKey
DRTS|Alpha Tau Medical Ltd|Price:12.690| - TradingKey
Alpha Tau Medical Ltd (DRTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alpha Tau Medical (DRTS) Is Down 7.7% After Reporting 100% Response In Alpha DaRT Combo Study - simplywall.st
Enterprise value to EBIT forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
DRTS|Alpha Tau Medical Ltd|Price:12.500|Chg%:-0.740 - TradingKey
Alpha Tau Medical Ltd. Revenue Breakdown – NASDAQ:DRTS - TradingView
Enterprise value to EBITDA forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Enterprise value to revenue forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
H.C. Wainwright reiterates Alpha Tau Medical stock rating at buy - Investing.com
H.C. Wainwright reiterates Alpha Tau Medical stock rating at buy By Investing.com - Investing.com UK
Alpha Tau Medical's (DRTS) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Alpha Tau Medical Ltd Stock (DRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):